We only have this paper's title and publication details.
Read it at the sourcePhase 1 trial reveals axi-cel product characteristics with utomilumab in relapsed large B-cell lymphoma, suggesting viable cell phenotypes.
Axi-cel Product Characteristics and Phenotype
No takes yet. Share an insight, caveat, or question.
Jain et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: